Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline
The DOI matches its Crossref record; 415 of the 415 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The objective of this document is to generate a practice guideline for the management and treatment of symptoms of the menopause. PARTICIPANTS: The Treatment of Symptoms of the Menopause Task Force included six experts, a methodologist, and a medical writer, all appointed by The Endocrine Society. EVIDENCE: The Task Force developed this evidenced-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned three systematic reviews of published data and considered several other existing meta-analyses and trials. CONSENSUS PROCESS: Multiple e-mail communications, conference calls, and one face-to-face meeting determined consensus. Committees of The Endocrine Society, representatives from endorsing societies, and members of The Endocrine Society reviewed and commented on the drafts of the guidelines. The Australasian Menopause Society, the British Menopause Society, European Menopause and Andropause Society, the European Society of Endocrinology, and the International Menopause Society (co-sponsors of the guideline) reviewed and commented on the draft. CONCLUSIONS: Menopausal hormone therapy (MHT) is the most effective treatment for vasomotor symptoms and other symptoms of the climacteric. Benefits may exceed risks for the majority of symptomatic postmenopausal women who are under age 60 or under 10 years since the onset of menopause. Health care professionals should individualize therapy based on clinical factors and patient preference. They should screen women before initiating MHT for cardiovascular and breast cancer risk and recommend the most appropriate therapy depending on risk/benefit considerations. Current evidence does not justify the use of MHT to prevent coronary heart disease, breast cancer, or dementia. Other options are available for those with vasomotor symptoms who prefer not to use MHT or who have contraindications because these patients should not use MHT. Low-dose vaginal estrogen and ospemifene provide effective therapy for the genitourinary syndrome of menopause, and vaginal moisturizers and lubricants are available for those not choosing hormonal therapy. All postmenopausal women should embrace appropriate lifestyle measures.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have not associated HRT in women 40-49 years with increased risk of breast cancer (161), and there is no evidence that estrogen replacement in women with premature ovarian failure relates to a higher risk of breast cancer ( 162).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [162]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889 · cited 3×
“(MPA) in women with a uterus (18), was associated with risks disproportionate to preventive benefits (17, 18).”
Background2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · cited 1×
“The Task Force followed the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group, an international group with expertise in development and implementation of evidence-based guidelines (1).”
Method2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
(2004) · JAMA · doi:10.1001/jama.291.14.1701 · Cited by 4,534 · cited 2×
“(MPA) in women with a uterus (18), was associated with risks disproportionate to preventive benefits (17, 18).”
BackgroundClinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149 · cited 2×
“Recent guidelines address bonespecific therapies (43).”
BackgroundWriting Group Members, Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.187998 · Cited by 3,711
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Systematic review and meta-analysis
(2019) · Providing Information for Health · doi:10.1201/9781315377315-19 · Cited by 2,659
Cited by
Items 701–800 of 883
Female Hypogonadism: Endocrinology of the Menopause and Hormone Replacement Therapy
Paschou, S. Α., Anagnostis, P. G., & Goulis, D. G. (2022) · doi:10.1093/med/9780198870197.003.0163 · Cited by 1
IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.051
Yu, S., He, X., Shi, H., Chen, Y., & Liu, Z. (2022) · Medicine · doi:10.1097/md.0000000000028597
Lundy, J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.022
IsHak, W. W., Mann, A., Manoukian, V., Pakhdikian, S., Chaudhry, M., Liu, A., & Bart, R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.001 · Cited by 2
Fisher, M. A., Johnson, A. L., & Bonnema, R. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-50695-7_8
Lukas, V. A., & Simon, J. A. (2020) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001607
Tramunt, B., & Gourdy, P. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-74372-6.00023-0
Baber, R. (2016) · Climacteric · doi:10.1080/13697137.2016.1250063
Sex Hormones and Related Compounds, Including Hormonal Contraceptives
Hrometz, S. L., & Say, S. P. (2017) · Side effects of drugs annual · doi:10.1016/bs.seda.2017.06.028
Williams, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-59058-1_1
Strowitzki, T. (2018) · Springer eBooks · doi:10.1007/978-3-662-57386-0_44
Strowitzki, T. (2017) · Springer eBooks · doi:10.1007/978-3-662-54630-7_44
Iron Overload Complication in Thalassemia Patients
Rotha, K. T. (2020) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v14i2.3409
Sepe, P., & Clouse, A. L. (2019) · Springer eBooks · doi:10.1007/978-3-030-18065-2_20
Schwabe, U., & Strowitzki, T. (2016) · Springer eBooks · doi:10.1007/978-3-662-50351-5_44
Mounier‐Véhier, C., & Madika, A. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-74372-6.00026-6
IsHak, W. W. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.053
Burt, V. K., Rasminsky, S., Murphy-Barzilay, E., & Suri, R. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372980.lr40
Burt, V. K., Rasminsky, S., Murphy-Barzilay, E., & Suri, R. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371501.lr40
TRATAMENTO NA MENOPAUSA: MEDICINA ORTOMOLECULAR DIFERENCIADA PARA UMA VIDA SAUDÁVEL
Rodrigues, F. D. A. A. (2022) · COGNITIONIS Scientific Journal · doi:10.38087/2595.8801.136
Screening for factors at midlife associated with reduced longevity in women
Bell, R. J. (2022) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002041
Wierman, M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-99918-6_23
Emerging drug delivery in the treatment of hyperpituitarism and hypopituitarism
Arora, V., Kabra, A., Puri, R., Vyas, G. K., Dua, K., & Dureja, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99616-7.00004-9 · Cited by 1
Rastreio do câncer de mama e indicadores socioeconômicos no Brasil
Santos, B. R., de Aguiar, J. E. A. T., Lira, J. M. C., Silva, T. S., & Dias, J. M. G. (2022) · Conjecturas · doi:10.53660/conj-1598-2h13
Endometrial hyperplasia, estrogen therapy, and the prevention of endometrial cancer
Ring, K. L., Pinkerton, J. V., Landrum, L. M., Zuna, R. E., & Duska, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-77684-4.00013-1 · Cited by 2
Self-citationHow should you advise your 54-year-old patient about the use of HT?
Mehta, J. M. (2022) · OBG Management · doi:10.12788/obgm.0220
“• For those with high 10-year CVD risk (>10%), HT is not recommended.(19,21)”
BackgroundCardiovascular health in menopause
van Jandrić, Goldštajn, M. Š., Orešković, S., Bolanča, I., Grizelj, B., & Mikuš, M. (2022) · Liječnički vjesnik · doi:10.26800/lv-144-11-12-7
Hormone Replacement Therapy after Gynaecological Cancer
Kaur, E. J., Baruah, U., Maheshwari, A., & Kataki, A. C. (2022) · Springer eBooks · doi:10.1007/978-981-19-5860-1_26
Endocrine Consequences Following Immune Checkpoint Inhibitors Therapy
Lavrentaki, A., & Ntali, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_172-1
EFICÁCIA DOS EXERCÍCIOS DE PILATES NA QUALIDADE DE VIDA EM MULHERES NA PÓS-MENOPAUSA: METANÁLISE
de Almeida, L. I. M., de Almeida, P. P., de Oliveira, R. G., & de Oliveira, L. C. (2023) · Anais do III Congresso Brasileiro de Saúde On-line · doi:10.51161/conbrasau2023/19129
“…dentre os diversos sintomas relatados por mulheres na pós-menopausa são: ondas de calor, distúrbios do sono, alterações do humor, depressão e alterações urogenitais, podendo comprometer dessa forma a qualidade de vida dessa população (BRASIL, 2008; ALSAFI; SANTORO, 2021; STUENKEL et al., 2015).”
BackgroundPart I: Interactive case: Menopause
Cieri‐Hutcherson, N. E., & Vernon, V. P. (2023) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1814
Goyal, A., Gupta, P., & Sturdee, D. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00010-7
Kling, J. M., & Faubion, S. S. (2023) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002236
FUNAYAMA, D. M. D. A., NEVES, G. S. P., Barbosa, I. D. S., & Rezende, I. S. (2023) · doi:10.59290/978-65-6029-029-7.9
Does vaginal estrogen use increase the risk for adverse cardiovascular outcomes?
Hendrix, J. (2023) · The Journal of Family Practice · doi:10.12788/jfp.0688
Turner, S., Allen, V. M., Graves, L. E., Tanguay, R. L., Green, C. R., & Cook, J. L. (2023) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2023.05.013 · Cited by 1
Lim, V. Z. (2023) · The Journal of Family Practice · doi:10.12788/jfp.0687
Treatment of Menopausal Symptoms with Herbal Medicines: A Review
Wal, P., Singh, I., Singh, D., Singh, M. R., & Wal, A. (2023) · Current Women s Health Reviews · doi:10.2174/0115734048262931231031162923 · Cited by 3
Changing Care in Changing World – Reproductive Marker of Cardiovascular Disease Risk in Women
Ahuja, M. (2023) · Journal of Mid-life Health · doi:10.4103/jmh.jmh_248_23
การใหฮอรโมนทดแทนในผปวยมะเรงนรเวช
Limsirisawat, W., Saeaib, N., & Peeyananjarassri, K. (2023) · PSU Medical Journal · doi:10.31584/psumj.2023261054
Maseroli, E., & Vignozzi, L. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108961097.042
Mason, I., Hewitt, G. D., McCracken, K. A., Whiteside, S. L., Nahata, L., & Kebodeaux, C. A. (2024) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2024.01.004
Klinik Uygulama Rehberleri Ebelik & Kadın Sağlığı
Akça, E. İ., Köroğlu, C. O., Demir, E., Alan, S., Öztürk, M., Akbaş, M., Dağlar, G., Güler, H., Özcan, H., Tokat, M. A., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.1139
Qin, L.-Q., Zhang, Z., Zhang, C.-F., & Zhou, H. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4747338
Osteopenia: Individualizing treatment—Part I
Hamdy, R. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99550-4.00009-5
Iyer, T. K., & Manson, J. E. (2024) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002364
Clain, E., & Santoro, N. F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00110-8
Nuevas terapias para el manejo de los síntomas vasomotores en la menopausia
Trujillo, J. P. L., & Vinueza, V. E. P. (2024) · Anatomía Digital · doi:10.33262/anatomiadigital.v7i3.3148
Fernandes, I. M. B., Medeiros, A. C., Milheiro, G. R., de Rezende, A. O., Dias, M. F. F. L., Franco, G. B., Nardelli, L. J., Barreto, S. N., de Faria, I. A. F. K., & de Faria, A. B. I. F. K. (2024) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v10i8.15477
Anastasio, M. K., Jhingran, A., & Sims, T. T. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009279864.015
Hormone Therapy and Contraception Management
Donohoe, F., Brennan, D. J., & Hickey, M. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009279864.006
Soto, M. A. R. (2024) · Estudios y Perspectivas Revista Científica y Académica · doi:10.61384/r.c.a..v4i3.588
de Almeida, L. I. M., de Oliveira, R. G., Ribeiro, L. G., Branco, L. V., Lucio, M. C. F., & de Oliveira, L. C. (2024) · Colloquium Vitae · doi:10.5747/cv.2024.v16.v382
Chapter 17. Schizophrenia and Related Disorders
Nagle-Yang, S. M., Friedman, S. H., Hasser, C., Mulvihill, A., Novick, A. M., Jones, A. K., Reed, E., & Sabhapathy, S. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg17
Valpey, R., Sachdeva, J., & Moel, J. E. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg22
Chapter 14. Integrative Approaches to Perinatal Depression
Becker, M. A., Hoffman, M. C., Ballone, N. T., & Shah, R. N. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg14
Chapter 20. Obsessive-Compulsive Disorder
Hudepohl, N. S., Leistikow, N., Levine, M., & Osborne, L. M. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg20
Chapter 10. A Treatment Approach to Psychiatric Emergencies in the Perinatal Period
Martinovic, J., Lakshmin, P., Zein, M., Olgun, M., & Hutner, L. A. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg10
Givrad, S., Paul, J. J., Wittmann, C., Nadal-Vicens, M. F., & John‐Larkin, C. S. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg12 · Cited by 1
Chapter 16. Postpartum Psychosis
Hasser, C., Martinovic, J., Lakshmin, P., Zein, M., Olgun, M., Hutner, L. A., Nagle-Yang, S. M., & Osborne, L. M. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg16
Chapter 19. Anxiety Disorders and Insomnia in the Perinatal Period
Hutner, L. A., MacLean, J. V., Guerrieri, G. M., Olgun, M., & Frew, J. R. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg19
Chapter 24. Forensic Issues in Perinatal Psychiatry
Friedman, S. H., Kaempf, A., Landess, J. S., & Kauffman, S. M. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg24
Chapter 11. Stress in Pregnancy: Impacts on Mother and Child
Takács, L., Babineau, V., & Monk, C. E. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg11 · Cited by 1
Leistikow, N., Smith, M. H., Williams, K. E., & Epperson, C. N. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg07
(2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.fm01
Chapter 8. A Clinical Approach to Psychiatric Diagnosis and Treatment During Pregnancy
Fitelson, E. M., Osborne, L. M., & Payne, J. L. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg08
Chapter 3. Female Sexual Dysfunctions and Reproductive Psychiatry
Kelley, E. L., Bastow, B., Lakshmin, P., & Kingsberg, S. A. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg03
Chapter 6. Premenstrual Mood Syndromes
Barzilay, E. M., Unverferth, K., & Obler, L. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg06
Appendix. Pregnancy and Lactation Considerations for Psychotropic Medications
(2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.bm01
Chapter 5. Infertility and Perinatal Loss
Hudepohl, N. S., Coker, J. L., Shivanekar, S. P., Nagalla, M.-L., Givrad, S., Standeven, L. R., Erdly, C., Jones, P., & Williams, K. E. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg05
(2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.index
Chapter 13. Depressive Disorders
Osborne, L. M., & Birndorf, C. A. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg13
Chapter 4. Contraception: Implications for Mental Health
Zhao, L. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg04
Chapter 2. Gynecological Conditions and Mental Health
Bastow, B., & Lakshmin, P. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg02
Chapter 23. Attention-Deficit/Hyperactivity Disorder
Hutner, L. A., Amin, J., Coulehan, J., Rao, M., Olgun, M., & Levine, M. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg23
Chapter 21. Substance Use Disorders
Frew, J. R., Augello, L. P., Doyle, M., Guille, C., Karabell, S., & Zhao, L. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg21
Chapter 15. Bipolar Disorder and Related Disorders
Nagle-Yang, S. M., DeBrunner, S. A., Favini, A., Novick, A. M., Hasser, C., Prakash, C., & Nathan, M. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg15
Chapter 9. A Clinical Approach to Psychiatric Diagnosis and Treatment in the Postpartum Period
Gorun, A., Zein, M., Olgun, M., & Catapano, L. A. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.lg09
Hutner, L. A., Catapano, L. A., Kelley, E. L., Kingsberg, S. A., Nagle-Yang, S. M., Williams, K. E., & Osborne, L. M. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379545.fm02
Managing menopause in women with diabetes
Mukherjee, A. (2024) · British Journal of Diabetes · doi:10.15277/bjd.2024.467
Menopause and Musculoskeletal Pain
Won, S. J. (2024) · Clinical Pain · doi:10.35827/cp.2024.23.2.84
ÇAKIR, C., & Yıldız, H. (2024) · Sağlık akademisyenleri dergisi/Sağlık akademisyenler dergisi · doi:10.52880/sagakaderg.1426994 · Cited by 1
The Effect of Menopause Hormone Therapy on Climacteric Symptoms
Castelo‐Branco, C., Ribera, L. B., & Hernández-Angeles, C. (2025) · Springer eBooks · doi:10.1007/978-3-031-83979-5_13
Yuk, J., Lee, J. L., Shin, Y., Han, G. H., Yoon, S., Kim, M., Noh, J. H., Lee, Y., Kim, J., Yoon, S.-Y., et al. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.113983
Uçar, N., Shirvani, A., & Holick, M. F. (2025) · Research Square · doi:10.21203/rs.3.rs-6173150/v1
Reame, N. K. (2025) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002586
Gompel, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00256-9
Self-citationIsmail, R. A., Shaheen, R. S., Afifi, E., Sayad, R., Sherif, L. N., Aranda, M., Gohary, R. A. A., & Elsaeidy, A. S. (2025) · Middle East Fertility Society Journal · doi:10.1186/s43043-025-00231-y · Cited by 2
“Thus, it is contraindicated in many women with a high risk of developing these conditions due to underlying medical disorders or the presence of other risk factors [11, 12].”
Abbood, M. S., Abbood, E. S., & Abed, D. N. (2025) · Reproductive health of woman · doi:10.30841/2708-8731.3.2025.331531
Current Concepts in Menopausal Hormone Therapy and Breast Cancer
Kling, J. M., & Pederson, H. J. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_9 · Cited by 1
Vaginal health in breast cancer survivors: a practical clinical approach
Ram, M., Paluch–Shimon, S., Allweis, T. M., & Lev‐Sagie, A. (2025) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359251344007 · Cited by 1
“12,22 Upon initiating therapy, subsequent follow-ups should evaluate symptom improvement, treatment adherence, and potential barriers.”
From Anatomy to Ecology: Distinguishing Localized from Systemic (Marrow-Centric) CancersPreprint
Catherino, D. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5344370
Association of hormone therapy with cardiovascular events in females using statins for prevention
Lukey, A., Stuart, G. C. E., Kaur, P., & Hanley, G. E. (2025) · Climacteric · doi:10.1080/13697137.2025.2524171
“The selection of confounders was informed by current practice guidelines for HT prescribing and previous work on HT use in CVD [6,24,29].”
Theerapakanunt, N., Jannoo, S., Leelawattana, R., & Kietsiriroje, N. (2025) · Archives of Osteoporosis · doi:10.1007/s11657-025-01606-4
“Based on these findings, current clinical guidelines advise against using HRT in women over 60 who have been menopausal for more than 10 years or have contraindications such as excess cardiovascular risk, and emphasize that HRT should not be used for primary CVD prevention [22, 23].”
Hidalgo-Avendaño, D., Álvarez, C. R. P., Ollero, S. S. H., Velasquez, X. F., Quispe, A., Gonzales, A. M., & Aguilar-Olano, J. L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.19.677269
Sato, T., Tachibana, M., Hiraga, H., Yokoyama, E., Watanabe, Z., & Saito, M. (2025) · Clinical Case Reports · doi:10.1002/ccr3.71077
Endocrine Consequences Following Immune Checkpoint Inhibitors Therapy
Lavrentaki, A., & Ntali, G. (2025) · Springer eBooks · doi:10.1007/978-3-032-00765-0_172
Comprehensive Guide to Menopausal Therapy: Options and Outcomes
Chatterjee, S., Sahoo, S., Khobragade, D. S., Prusty, S. K., Sahu, P. K., Tiwari, P. K., & Kadiri, S. K. (2025) · Current Women s Health Reviews · doi:10.2174/0115734048352354250406163635
Metadata
- Authors
- Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-11
- Volume
- 100
- Issue
- 11
- Pages
- 3975-4011
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2162957019
- Cited by
- 884
- References
- 414
- Citations by year
- 2026: 79 · 2025: 96 · 2024: 66 · 2023: 69 · 2022: 82 · 2021: 96 · 2020: 121 · 2019: 89 · 2018: 75 · 2017: 57 · 2016: 47 · 2015: 4
- FWCI
- 52.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- menopause, hormone replacement therapy, vasomotor symptoms, climacteric, postmenopausal women, cardiovascular risk screening, breast cancer risk, ospemifene, vaginal estrogen, genitourinary syndrome of menopause, vaginal moisturizers, lifestyle intervention, personalized treatment
- MeSH terms
- Contraindications, Age Factors, Breast Neoplasms, Cardiovascular Diseases, Female, Humans, Menopause, Terminology as Topic, Risk Factors, Severity of Illness Index, Estrogen Replacement Therapy, Evidence-Based Medicine, Hot Flashes, Female Urogenital Diseases, Venous Thromboembolism, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.